REX(REX)
REX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E |
|---|---|
| Revenue Avg | $769M |
| Low | $769M |
| High | $769M |
| EBITDA Avg | $183M |
| Low | $183M |
| High | $183M |
| EBIT Avg | $164M |
| Low | $164M |
| High | $164M |
| Net Income Avg | $50M |
| Low | $50M |
| High | $50M |
| EPS Avg | $1.50 |
| Low | $1.50 |
| High | $1.50 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $195M | $207M | $201M |
| Low | $195M | $207M | $201M |
| High | $195M | $207M | $201M |
| EBITDA Avg | $46M | $49M | $48M |
| Low | $46M | $49M | $48M |
| High | $46M | $49M | $48M |
| EBIT Avg | $41M | $44M | $43M |
| Low | $41M | $44M | $43M |
| High | $41M | $44M | $43M |
| Net Income Avg | $14M | $17M | $13M |
| Low | $14M | $17M | $13M |
| High | $14M | $17M | $13M |
| EPS Avg | $0.42 | $0.53 | $0.41 |
| Low | $0.42 | $0.53 | $0.41 |
| High | $0.42 | $0.53 | $0.41 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |